ADL
BMY.RT

Asset Dedication LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Asset Dedication LLC’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,531
Closed – – 814
2020
Q4 		$0 Sell
1,531
-56
-4% -$119 ﹤0.01% 832
2020
Q3 		$2K Hold
1,587
– – ﹤0.01% 710
2020
Q2 		$4K Hold
1,587
– – ﹤0.01% 557
2020
Q1 		$4K Sell
1,587
-28
-2% -$92 ﹤0.01% 542
2019
Q4 		$4K Buy
+1,615
New +$4.2K ﹤0.01% 575

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Asset Dedication LLC's BMY.RT Position: Q1 2021 in Review

Asset Dedication LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,531 shares.

Asset Dedication LLC first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $4K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Asset Dedication LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Asset Dedication LLC sold 1,531 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Asset Dedication LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Asset Dedication LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $4K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Asset Dedication LLC's 13F filing for Q1 2021, filed 3 May 2021.